Vapotherm, Inc. (VAPO): Price and Financial Metrics

Vapotherm, Inc. (VAPO): $0.82

0.02 (+2.50%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

D

Add VAPO to Watchlist
Sign Up

Industry: Medical - Consumer Goods

Industry

B

Ranked

#9 of 10

in industry

VAPO Price/Volume Stats

Current price $0.82 52-week high $5.44
Prev. close $0.80 52-week low $0.70
Day low $0.82 Volume 7,500
Day high $0.82 Avg. volume 10,567
50-day MA $1.10 Dividend yield N/A
200-day MA $1.75 Market Cap 5.10M

VAPO Stock Price Chart Interactive Chart >


Vapotherm, Inc. (VAPO) Company Bio


Vapotherm Inc. Vapotherm, Inc. is a global medical technology company. The Company is focused on the development and commercialization of its high velocity nasal insufflations (Hi-VNI) technology products that are used to treat patients suffering from respiratory distress. Its Hi-VNI technology delivers noninvasive ventilatory support by providing heated, humidified and oxygenated air at a high velocity to patients through a comfortable small-bore nasal interface. Its Precision Flow systems uses its Hi-VNI technology. It offers three versions of its Precision Flow systems: Precision Flow Plus, Precision Flow Classic and Precision Flow Heliox. Its Precision Flow systems include a capital unit, a single-use disposable and a nasal interface. Its Precision Flow versions are integrated systems that provide precise user control of temperature, air flow and percentage oxygen through a one-button interface.


VAPO Latest News Stream


Event/Time News Detail
Loading, please wait...

VAPO Latest Social Stream


Loading social stream, please wait...

View Full VAPO Social Stream

Latest VAPO News From Around the Web

Below are the latest news stories about VAPOTHERM INC that investors may wish to consider to help them evaluate VAPO as an investment opportunity.

OTC Markets Group Welcomes Vapotherm, Inc. to OTCQX

NEW YORK, Dec. 15, 2023 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for 12,000 U.S. and international securities, today announced Vapotherm, Inc. (OTCQX: VAPO), a global medical technology company specializing in the development and commercialization of its proprietary Vapotherm high-velocity therapy® products for patients of all ages experiencing respiratory distress, has qualified to trade on the OTCQX® Best Market. Vapotherm, Inc. voluntarily transf

Yahoo | December 15, 2023

Vapotherm Announces Suspension of NYSE Listing Common Stock Expected to Begin Trading Promptly on OTCQX

Vapotherm, Inc. (NYSE: VAPO), ("Vapotherm" or the "Company") today announced it has received notice that the New York Stock Exchange ("NYSE") has determined to suspend trading of – and commence proceedings to delist – shares of the Company's common stock, effective immediately. This suspension was made because the Company fell below the NYSE's continued listing standard requiring listed companies to maintain an average global market capitalization over a consecutive 30 trading day period of at l

Yahoo | December 14, 2023

Vapotherm Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock Application Pending to Transfer Shares to OTCQX

Vapotherm, Inc. (NYSE: VAPO), ("Vapotherm" or the "Company") today announced its intention to voluntarily delist its common stock from The New York Stock Exchange ("NYSE") and its filing of an application to have its common stock quoted on the OTCQX Marketplace ("OTCQX").

Yahoo | December 11, 2023

Vapotherm Educates over 8,000 Clinicians in Respiratory Care Month

Vapotherm, Inc. (NYSE: VAPO), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy® products, which are used to treat patients of all ages suffering from respiratory distress is excited to announce the participation of over 8,000 clinicians in interactive, digital based, evidence based education focused on a variety of respiratory clinical topics. The education was free to clincians in celebration of Respiratory C

Yahoo | November 28, 2023

Vapotherm, Inc. (NYSE:VAPO) Q3 2023 Earnings Call Transcript

Vapotherm, Inc. (NYSE:VAPO) Q3 2023 Earnings Call Transcript November 8, 2023 Vapotherm, Inc. misses on earnings expectations. Reported EPS is $-2.38 EPS, expectations were $-2.2. Operator: Good afternoon, and welcome to Vapotherm’s Third Quarter 2023 Financial Results Conference Call. [Operator Instructions] It is now my pleasure to turn today’s conference over to Dorota Mckay, Vapotherm’s […]

Yahoo | November 10, 2023

Read More 'VAPO' Stories Here

VAPO Price Returns

1-mo -4.65%
3-mo -39.26%
6-mo -8.89%
1-year -82.62%
3-year -99.57%
5-year -99.51%
YTD -18.00%
2023 -95.37%
2022 -86.96%
2021 -22.90%
2020 120.89%
2019 -39.05%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!